The new test works by detecting two sugars—CA199.STRA and CA19-9—that are produced by pancreatic cancer cells and escape into ...

The trial will be a case-control study evaluating the accuracy of the next-generation test in differentiating blood samples from people with early-stage pancreatic cancer from individuals without it.

Avantect Pancreatic Cancer Test Cost-Effective When Used as a Surveillance Tool in High-Risk Patients Newly Diagnosed with ...

Immunovia is focused on the development and commercialization of simple blood-based ... groups to make its test available to individuals at increased risk for pancreatic cancer.

November is Pancreatic Cancer Awareness Month. Did you know that pancreatic cancer is the third-leading cause of cancer-related death in the U.S.?

Approximately 1 in 56 men and 1 in 60 women will be diagnosed with pancreatic cancer at some point in their lives, and Pennsylvania has slightly higher rates of pancreatic ...

People of Ashkenazi Jewish descent are at higher risk of developing pancreatic cancer because they are more likely than other ...

Immunovia (NASDAQ STOCKHOLM: IMMNOV), the pancreatic cancer diagnostics company, will present an update on its next-generation test at the annual meeting of the PRECEDE Consortium, a collaboration of ...

including early detection blood tests and advances in AI-based imaging. The Pancreatic Cancer Early Detection and Prevention Clinic at UC San Diego Health offers clinical evaluation and ...

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters. The findings pave the way for further ...